EUVIMEDEUVIMED entdecken
Crossref

Point of Care Immunoassay Drugs of Abuse Screening in a Post Mortem Population

Hartel Paul, O’Connell Sinead, O’Grady Liam, Molloy Louise, Cassella John, Dowling Geraldine

International Journal of Forensic Science & Research · 2025

DOI: 10.33425/3066-3830.1008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Forensic Science & Research, 2025. Verfasst von Hartel Paul und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To test the utility of point-of-care immunoassay testing of drugs of abuse in a post-mortem population, we compared immunoassay near-body drugs of abuse results with liquid/gas chromatography-mass spectrometry confirmatory testing. While immunoassay results are subject to false positives from decompositional amines and prescription medications, negative screening tests can produce significant cost-savings and allow for timelier autopsy reports where confirmatory testing is unnecessary. This would also help ease the burden on reference and/or State laboratories and save approximately 500,000 euros per annum across the health system.

Zitieren

APA

Paul, H., Sinead, O., Liam, O., Louise, M., John, C., & Geraldine, D. (2025). Point of Care Immunoassay Drugs of Abuse Screening in a Post Mortem Population. International Journal of Forensic Science & Research. https://doi.org/10.33425/3066-3830.1008

Vancouver

Paul H, Sinead O, Liam O, Louise M, John C, Geraldine D. Point of Care Immunoassay Drugs of Abuse Screening in a Post Mortem Population. International Journal of Forensic Science & Research. 2025. doi:10.33425/3066-3830.1008

BibTeX
@article{Paul2025,
  author = {Paul, Hartel and Sinead, O’Connell and Liam, O’Grady and Louise, Molloy and John, Cassella and Geraldine, Dowling},
  title = {Point of Care Immunoassay Drugs of Abuse Screening in a Post Mortem Population},
  journal = {International Journal of Forensic Science & Research},
  year = {2025},
  doi = {10.33425/3066-3830.1008}
}
Kostenlos starten →